{
  "projects": [
    {
      "title": "Regulatory Compliance Review for EU Market",
      "category": "Regulatory Affairs",
      "status": "In Progress",
      "description": "Reviewing all product documentation and labeling to ensure compliance with EMA standards for upcoming submissions.",
      "id": "bf7c"
    },
    {
      "title": "Development of a New Antiviral Drug",
      "category": "Research & Development",
      "status": "Completed",
      "description": "Research and development of a novel antiviral compound targeting RNA viruses, with initial focus on influenza strains.\n",
      "id": "d2d4"
    },
    {
      "title": "linical Trials for Hypertension Medication â€“ Phase II",
      "category": "Clinical Trials",
      "status": "Pending",
      "description": "Evaluating the safety and efficacy of a newly formulated antihypertensive drug in Phase II clinical trials.",
      "id": "7024"
    },
    {
      "title": "GMP Training",
      "category": "Training",
      "status": "In Progress",
      "description": "Training on Good Manufacturing Practice.",
      "id": "9b6e"
    },
    {
      "title": "Cancer Drug Trial Face I",
      "category": "Formulation Process",
      "status": "Completed",
      "description": "Formulation of Cancer Drug",
      "id": "d0aa"
    }
  ],
  "tasks": [
    {
      "id": "9d4f",
      "title": "Hypertension Trials ",
      "description": "",
      "dueDate": "2025-05-02",
      "priority": "High",
      "projectId": "7024",
      "status": "In Progress"
    },
    {
      "title": "Compliance Review",
      "dueDate": "2025-10-06",
      "status": "Pending",
      "id": "f3df"
    },
    {
      "id": "1a5a",
      "title": "New Antiviral Drug",
      "description": "Development of a New Antiviral Drug",
      "dueDate": "2025-03-06",
      "priority": "High",
      "projectId": "d2d4",
      "status": "Completed"
    },
    {
      "title": "Lead Trainer ",
      "dueDate": "2025-05-10",
      "status": "Pending",
      "id": "86c1"
    },
    {
      "id": "5643",
      "title": "Cancer Drug Formulation",
      "description": "",
      "dueDate": "2025-12-05",
      "priority": "High",
      "projectId": "d0aa",
      "status": "Pending"
    },
    {
      "id": "f70f",
      "title": "Regulatory Compliance",
      "description": "",
      "dueDate": "2025-10-05",
      "priority": "Medium",
      "projectId": "bf7c",
      "status": "Pending"
    }
  ],
  "compliance": [
    {
      "id": "304a",
      "document": "Mefanther Research",
      "status": "Pending",
      "reviewedBy": "Pharm Owodunni",
      "dueDate": "52025-02-01"
    },
    {
      "id": "bfba",
      "document": "GMP Certificate",
      "status": "Approved",
      "reviewedBy": "Dr. Smith",
      "dueDate": "2025-05-11"
    },
    {
      "id": "99ab",
      "document": "ISO 13485 Audit",
      "status": "Pending",
      "reviewedBy": "Auditor Jane",
      "dueDate": "2025-05-06"
    }
  ],
  "reports": [
    {
      "title": "New Product Approval",
      "date": "2025-10-05",
      "summary": "Approval of Mefanther Product to caution the effect of Malaria.",
      "link": "https://example.com/reports/productapproval-2025.pdf",
      "id": "c202"
    },
    {
      "title": "GMP Compliance",
      "date": "2025-05-11",
      "summary": "Monitoring and Regulating Standards.",
      "link": "https://example.com/reports/GMPcompliance-2025.pdf",
      "id": "761f"
    }
  ]
}